The past president of the SVMB shares his insight on board certification, turf battles, and future vascular disease therapies.
By Michael R. Jaff, DO
Does the availability of endovascular grafts change the size threshold for repair?
By Kenneth Ouriel, MD
Screening high-risk patients for AAAs.
By John Wiest, MD
Legislation pending before Congress would provide for Medicare reimbursement for screening procedures that can save lives.
By Takao Ohki, MD, PhD and Craig McChesney, Publisher
Is endovascular aneurysm repair better than open repair, or is the race still on?
By Jan D. Blankensteijn, MD
Taking vascular disease screening and community awareness to the next level.
By John D. Martin, MD; Louise Hanson, CRNP; and Jon Hupp, MD
An overview of the progress to date and expanding initiatives for the near future.
By SVS/AVA Outcomes Registry Steering Committee
Techniques and technologies involving branched or fenestrated devices have emerged to offer new EVAR options.
By Roy K. Greenberg, MD
What exhibitors need to know about the FDA’s authority.
By Dorothy B. Abel and Angela C. Smith
A summary of the 8th Morgan Stanley Interventional Cardiology Conference provides insight into the trends that will be affecting endovascular care for the next several years.